AVRICORE HEALTH INC | 6-K: Report of foreign private issuer (related to financial reporting)
Avricore Health Announces Strong Full-year Financial and Strategic Growth | TSX-V:AVCR, OTC:AVCRF
Avricore Expands HealthTab Partnership With Rexall Pharmacy | TSX-V:AVCR, OTC:AVCRF
Avricore Grants Options
VANCOUVER, British Columbia, May 15, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or "AVCR") today announces that the Company's board of directors has approved the grant
Avricore Health GAAP EPS of C$0.01, Revenue of C$1.77M
Avricore Health Corporate Updates on Audited Results for 2022
The Company will host an investor update call on May 3rd with CEO Hector Bremner to share the Company's outlook and take questionsVANCOUVER, British Columbia, May 02, 2023 (GLOBE NEWSWIRE) -- AVRICO
Avricore Health Reports Q2 Reults
Avricore Health press release (OTC:AVCRF): Q2 GAAP EPS of $0.00. Revenue of $176.17K (+3466.2% Y/Y).
No Data